Insider Buying: Cosmos Health Inc. (NASDAQ:COSM) CEO Buys $66,403.35 in Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas purchased 147,563 shares of the stock in a transaction that occurred on Tuesday, May 20th. The stock was bought at an average price of $0.45 per share, with a total value of $66,403.35. Following the completion of the acquisition, the chief executive officer now owns 5,808,883 shares in the company, valued at $2,613,997.35. This represents a 2.61% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Grigorios Siokas also recently made the following trade(s):

• On Thursday, May 22nd, Grigorios Siokas acquired 141,825 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.44 per share, with a total value of $62,403.00.
• On Wednesday, May 21st, Grigorios Siokas acquired 174,172 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.47 per share, with a total value of $81,860.84.
• On Monday, May 19th, Grigorios Siokas acquired 79,254 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.43 per share, with a total value of $34,079.22.
• On Wednesday, April 23rd, Grigorios Siokas acquired 205,000 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.40 per share, with a total value of $82,000.00.
• On Monday, April 21st, Grigorios Siokas acquired 654,912 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.32 per share, with a total value of $209,571.84.
• On Monday, March 3rd, Grigorios Siokas acquired 132,572 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.49 per share, with a total value of $64,960.28.
• On Monday, February 24th, Grigorios Siokas acquired 354,296 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.56 per share, with a total value of $198,405.76.

Cosmos Health Stock Performance

NASDAQ:COSM opened at $0.45 on Friday. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.44 and a quick ratio of 1.24. The firm has a 50-day moving average of $0.42 and a two-hundred day moving average of $0.59. The stock has a market cap of $12.87 million, a P/E ratio of -0.18 and a beta of 5.50. Cosmos Health Inc. has a 1-year low of $0.28 and a 1-year high of $1.58.

Cosmos Health (NASDAQ:COSM) last issued its quarterly earnings results on Thursday, May 15th. The company reported $0.01 EPS for the quarter. Cosmos Health had a negative net margin of 36.39% and a negative return on equity of 9.39%. On average, research analysts expect that Cosmos Health Inc. will post -0.78 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Armistice Capital LLC lifted its stake in shares of Cosmos Health Inc. (NASDAQ:COSM) by 156.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,917,710 shares of the company’s stock after purchasing an additional 1,168,884 shares during the period. Armistice Capital LLC owned about 7.03% of Cosmos Health worth $836,000 as of its most recent filing with the SEC. Hedge funds and other institutional investors own 12.61% of the company’s stock.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.